Stem Cell Blog
Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.
Renowned cord blood scientist and researcher Hal Broxmeyer has been awarded a Lifetime Achievement Award by the Cord Blood Association, which counts Cells4Life among its members.
The award, which last year went to Eliane Gluckman MD, recognises Broxmeyer’s significant contributions to cord blood research, which date back more than 30 years.
The future of cord blood for regenerative medicine is bright.
That was abundantly clear from this year’s World Advanced Therapies & Regenerative Medicine Congress, which is now in its fifth year.
Once again, the congress brought together more than 1,000 attendees for three days of seminars and lectures, which were presented by some of the world’s most renowned stem cell scientists.
More parents are choosing private cord blood banking than ever before, according to new statistics published by the BBC.
The numbers, which come from the Human Tissue Authority (HTA), show that there was an incredible 60% increase in cord blood collection and storage between 2014 and 2018.
The rise suggests that young families are increasingly recognising the benefits of their baby’s umbilical cord, which is one of the richest sources of stem cells they will ever have.
20/01/2024 BlogNewsStem Cell News
Aditi Shankar is just eight years old, but she is a pioneer of British medicine thanks to a new way in which she has received a kidney transplant. But first, a little about the girl.
Aditi has the rarest form of dwarfism in the world, Schimke immuno-osseous dysplasia (SIOD). The condition is so rare that it affects only one in one to three million people worldwide. A genetic disorder, SIOD leads to sufferers needing hip transplants, bone marrow transplants, and kidney failure. Unfortunately, the life expectancy of those with this condition is incredibly short at 11 years of age.
20/01/2024 BlogNewsStem Cell News
We’re excited to share some promising results from a recent clinical trial that holds great promise for treating Type 1 diabetes.
This ground-breaking research was presented at the American Diabetes Association‘s 83rd Scientific Sessions on June 23, 2023. The study involved six patients who were administered varying doses of stem cell-derived beta cells. The results were nothing short of remarkable.
20/01/2024 BlogStem Cell News
Stem cell banking gives your child access to a huge range of emerging stem cell therapies that may otherwise be unavailable to them. The idea is that as they age their perfectly matched, banked stem cells are ready and waiting to repair damaged tissue, for example regenerating cartilage if they suffer from arthritis, or treat debilitating and ultimately terminal age related conditions such as Parkinson’s.
20/01/2024 BlogNewsStem Cell News
The doctor who treated seven-time World Champion driver, Michael Schumacher with stem cell therapy following his traumatic brain injury is now using the same treatment to help treat coronavirus.
Back in June, renowned clinical cardiac surgeon Professor Philippe Menasché performed pioneering stem cell treatment on the Formula 1 icon. Schumacher is said to have received transfusions of stem cells to reduce inflammation and help regenerate his nervous system after sustaining a life-changing brain injury almost 7 years ago.
20/01/2024 BlogStem Cell News
2020 has been a difficult year. But the unprecedented challenges posed by the COVID-19 pandemic have also helped drive huge leaps forward in medical science.
We’ve taken some time to reflect and summarise some of the significant advancements that have been made in the last 12 months; both here at Cells4Life, and in the wider stem cell field.
20/01/2024 BlogStem Cell News
Researchers at Kyoto University’s Centre for iPS Cell Research and Application in Japan are moving ahead with the world’s first application of induced pluripotent stem cells (iPSCs) to treat Parkinson’s disease.
The team, led by neurosurgeon Jun Takahashi, will now engage in a limited clinical trial to test the potential side effects.
Cells4Life Group LLP,
Units 2-3 Oak House, Woodlands Office Park,
Albert Drive, Burgess Hill, RH15 9TN, UK.
Med Bio Genetics
Pero Nakov 110, Skopje, Republic Macedonia
+389 70 221 602
info@cells4life.mk
